WO2001051635A3 - Novel stra6 polypeptides - Google Patents

Novel stra6 polypeptides Download PDF

Info

Publication number
WO2001051635A3
WO2001051635A3 PCT/US2001/000847 US0100847W WO0151635A3 WO 2001051635 A3 WO2001051635 A3 WO 2001051635A3 US 0100847 W US0100847 W US 0100847W WO 0151635 A3 WO0151635 A3 WO 0151635A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
present
nucleic acid
novel
sequences
Prior art date
Application number
PCT/US2001/000847
Other languages
French (fr)
Other versions
WO2001051635A2 (en
Inventor
Diane Pennica
Victoria Smith
William I Wood
Original Assignee
Genentech Inc
Diane Pennica
Victoria Smith
William I Wood
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU32768/01A priority Critical patent/AU785055B2/en
Priority to NZ520095A priority patent/NZ520095A/en
Priority to DE60137829T priority patent/DE60137829D1/en
Priority to CA2397207A priority patent/CA2397207C/en
Application filed by Genentech Inc, Diane Pennica, Victoria Smith, William I Wood filed Critical Genentech Inc
Priority to JP2001551209A priority patent/JP2003519491A/en
Priority to DK01904821T priority patent/DK1246917T3/en
Priority to CN018064965A priority patent/CN1425066B/en
Priority to IL15067601A priority patent/IL150676A0/en
Priority to EP01904821A priority patent/EP1246917B1/en
Publication of WO2001051635A2 publication Critical patent/WO2001051635A2/en
Priority to US10/119,480 priority patent/US20040087769A1/en
Publication of WO2001051635A3 publication Critical patent/WO2001051635A3/en
Priority to IL150676A priority patent/IL150676A/en
Priority to KR1020027009049A priority patent/KR100929057B1/en
Priority to AU2006241374A priority patent/AU2006241374B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

The present invention is directed to novel polypeptides having sequence similarity to Stra6, a murine retinoic acid responsive protein, and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
PCT/US2001/000847 1998-09-10 2001-01-11 Novel stra6 polypeptides WO2001051635A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DK01904821T DK1246917T3 (en) 2000-01-13 2001-01-11 Human Stra6 polypeptides
DE60137829T DE60137829D1 (en) 2000-01-13 2001-01-11 HUMAN STRA6 POLYPEPTIDE
CA2397207A CA2397207C (en) 2000-01-13 2001-01-11 Novel stra6 polypeptides
IL15067601A IL150676A0 (en) 2000-01-13 2001-01-11 NOVEL STRa6 POLYPEPTIDES
JP2001551209A JP2003519491A (en) 2000-01-13 2001-01-11 Novel STRA6 polypeptide
NZ520095A NZ520095A (en) 2000-01-13 2001-01-11 Novel Stra6 polypeptides, nucleic acids, antibodies, compositions and methods of treatments for inhibiting tumor cell growth
CN018064965A CN1425066B (en) 2000-01-13 2001-01-11 Novel stra6 polypeptides
AU32768/01A AU785055B2 (en) 2000-01-13 2001-01-11 Novel stra6 polypeptides
EP01904821A EP1246917B1 (en) 2000-01-13 2001-01-11 Human stra6 polypeptides
US10/119,480 US20040087769A1 (en) 1998-09-10 2002-04-09 Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL150676A IL150676A (en) 2000-01-13 2002-07-10 Stra6 antibodies and uses thereof
KR1020027009049A KR100929057B1 (en) 2000-01-13 2002-07-12 New Stratea6 Polypeptide
AU2006241374A AU2006241374B2 (en) 2000-01-13 2006-11-24 Novel Stra6 polypeptides

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US17584900P 2000-01-13 2000-01-13
US60/175,849 2000-01-13
US19708900P 2000-04-14 2000-04-14
US60/197,089 2000-04-14
US22891400P 2000-08-29 2000-08-29
US60/228,914 2000-08-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/119,480 Continuation US20040087769A1 (en) 1998-09-10 2002-04-09 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Publications (2)

Publication Number Publication Date
WO2001051635A2 WO2001051635A2 (en) 2001-07-19
WO2001051635A3 true WO2001051635A3 (en) 2002-05-02

Family

ID=27390600

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/000847 WO2001051635A2 (en) 1998-09-10 2001-01-11 Novel stra6 polypeptides

Country Status (15)

Country Link
US (7) US7173115B2 (en)
EP (1) EP1246917B1 (en)
JP (2) JP2003519491A (en)
KR (2) KR20080006002A (en)
CN (2) CN101643733A (en)
AT (1) ATE424457T1 (en)
AU (2) AU785055B2 (en)
CA (1) CA2397207C (en)
DE (1) DE60137829D1 (en)
DK (1) DK1246917T3 (en)
ES (1) ES2323220T3 (en)
IL (2) IL150676A0 (en)
NZ (1) NZ520095A (en)
PT (1) PT1246917E (en)
WO (1) WO2001051635A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60137829D1 (en) * 2000-01-13 2009-04-16 Genentech Inc HUMAN STRA6 POLYPEPTIDE
WO2002077027A1 (en) * 2000-03-23 2002-10-03 Curagen Corporation Human stra6-like protein and nucleic acids encoding the same
CN1339489A (en) * 2000-08-23 2002-03-13 上海博德基因开发有限公司 New polypeptide-human retinoic acid modulator protein 53.57 and polynucleotide for encoding such polypeptide
JP2004507251A (en) * 2000-08-29 2004-03-11 ジェネンテック・インコーポレーテッド Methods for enhancing the therapeutic effect of cancer
AU2002308557A1 (en) * 2001-05-01 2002-11-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
ES2486265T3 (en) * 2002-03-13 2014-08-18 Genomic Health, Inc. Obtaining gene expression profile in biopsied tumor tissues
US7666627B2 (en) * 2002-08-08 2010-02-23 Targetex Kft. Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof
WO2004039412A2 (en) * 2002-10-29 2004-05-13 Engene, Inc. Compositions for cancer treatment
CA2524172A1 (en) * 2003-04-30 2004-11-18 Centocor, Inc. Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
US7780721B2 (en) * 2004-09-01 2010-08-24 C. R. Bard, Inc. Stent and method for manufacturing the stent
WO2008089438A2 (en) * 2007-01-18 2008-07-24 The Regents Of The University Of California A membrane receptor for retinol binding protein mediates cellular uptake of vitamin a, methods of use and compositions
US20110159017A1 (en) * 2008-04-11 2011-06-30 Ludwig Institute For Cancer Research Ltd. Trytophan catabolism in cancer treatment and diagnosis
US20120183477A1 (en) * 2009-06-26 2012-07-19 Five Prime Therapeutics, Inc. Therapeutic Antibody Target Validation and Screening In Vivo
SG181806A1 (en) * 2010-01-11 2012-07-30 Genomic Health Inc Method to use gene expression to determine likelihood of clinical outcome of renal cancer
ES2925983T3 (en) * 2010-07-27 2022-10-20 Genomic Health Inc Method for using gene expression to determine prostate cancer prognosis
EP3179393B1 (en) 2012-01-31 2020-07-08 Genomic Health, Inc. Gene expression profile algorithm and test for determining prognosis of prostate cancer
KR102148303B1 (en) 2012-02-11 2020-08-26 제넨테크, 인크. R-spondin translocations and methods using the same
JP2016521979A (en) 2013-05-30 2016-07-28 ジェノミック ヘルス， インコーポレイテッド Gene expression profiling algorithm for calculating recurrence score for patients with kidney cancer
EP3636661A1 (en) * 2018-10-12 2020-04-15 Bioc3 Phosphate translocator

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
WO2001012660A2 (en) * 1999-08-17 2001-02-22 Sagami Chemical Research Center HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2413974A1 (en) 1978-01-06 1979-08-03 David Bernard DRYER FOR SCREEN-PRINTED SHEETS
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
WO1981001145A1 (en) 1979-10-18 1981-04-30 Univ Illinois Hydrolytic enzyme-activatible pro-drugs
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4444545A (en) * 1982-04-08 1984-04-24 Sanders David F Pump control system
US4943529A (en) 1982-05-19 1990-07-24 Gist-Brocades Nv Kluyveromyces as a host strain
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
AU3145184A (en) 1983-08-16 1985-02-21 Zymogenetics Inc. High expression of foreign genes in schizosaccharomyces pombe
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
DE3675588D1 (en) 1985-06-19 1990-12-20 Ajinomoto Kk HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE).
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
AU597574B2 (en) 1986-03-07 1990-06-07 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
US4676417A (en) * 1986-04-14 1987-06-30 Richard Hirschkoff Ski carrier
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
US4997852A (en) * 1987-08-26 1991-03-05 Ohio State University Research Foundation Method and composition for achieving cancer chemopreventive and chemotherapeutic activity
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
KR0154872B1 (en) 1987-12-21 1998-10-15 로버트 에이. 아미테이지 Agrobacterium mediated transformation of germinating plant seeds
SE8802525L (en) 1988-07-06 1990-01-07 Fmg Filipstad Ab CHAIR
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5009772A (en) 1989-02-27 1991-04-23 Kerr-Mcgee Corporation Solvent extraction process
DE394538T1 (en) 1989-04-28 1991-04-11 Rhein Biotech Ges. Fuer Biotechnologische Prozesse Und Produkte Mbh, 4000 Duesseldorf, De YEAR CELLS OF THE SCHWANNIOMYCES GENERATION.
FR2646437B1 (en) 1989-04-28 1991-08-30 Transgene Sa NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME
WO1990013641A1 (en) 1989-05-10 1990-11-15 Sloan-Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
DE3920358A1 (en) 1989-06-22 1991-01-17 Behringwerke Ag BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
EP0739904A1 (en) 1989-06-29 1996-10-30 Medarex, Inc. Bispecific reagents for aids therapy
FR2649120B1 (en) 1989-06-30 1994-01-28 Cayla NOVEL STRAIN AND ITS MUTANTS OF FILAMENTOUS MUSHROOMS, PROCESS FOR PRODUCING RECOMBINANT PROTEINS USING SAID STRAIN, AND STRAINS AND PROTEINS OBTAINED BY SAID METHOD
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
DK0814159T3 (en) 1990-08-29 2005-10-24 Genpharm Int Transgenic, non-human animals capable of forming heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
EP0617706B1 (en) 1991-11-25 2001-10-17 Enzon, Inc. Multivalent antigen-binding proteins
US5731167A (en) 1992-01-17 1998-03-24 The United States Of America As Represented By The Department Of Health And Human Services Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
US5756448A (en) 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
CA2131543C (en) 1992-03-04 2002-09-17 Daniel Pinkel Comparative genomic hybridization
PT752248E (en) 1992-11-13 2001-01-31 Idec Pharma Corp THERAPEUTIC APPLICATION OF QUIMERIC ANTIBODIES AND RADIOACTIVELY MARKING OF ANTIGENES OF RESTRICTED DIFFERENTIATION OF HUMAN LYMPHOCYTE B FOR THE TREATMENT OF B-CELL LYMPHOMA
ATE195652T1 (en) 1992-12-02 2000-09-15 Alkermes Inc CONTROLLED RELEASE MICROSPHERES CONTAINING GROWTH HORMONE
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
ATE186219T1 (en) 1993-03-24 1999-11-15 Berlex Biosciences COMBINATION OF ANTIHORMONAL AND BINDING MOLECULES FOR CANCER TREATMENT
US5681860A (en) * 1993-09-21 1997-10-28 The Trustees Of Columbia University In The City Of New York Method of increasing expression of HLA, cell surface and TAA antigens of cells using 3-(N-acetylamino)-5-(N-decyl-N-methylamino)-benzyl alcohol
EP0779806B2 (en) 1994-09-09 2008-04-16 Takeda Pharmaceutical Company Limited Sustained release preparation containing metal salt of a peptide
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6316007B1 (en) 1995-04-04 2001-11-13 Wound Healing Of Oklahoma Combined physical and immunotherapy for cancer
CZ288147B6 (en) 1995-06-07 2001-05-16 Alkermes Inc Preparation for prolonged release of human growth hormone
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US5871697A (en) * 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
AU2582897A (en) 1996-03-15 1997-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
US6525174B1 (en) * 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
DE60137829D1 (en) * 2000-01-13 2009-04-16 Genentech Inc HUMAN STRA6 POLYPEPTIDE
WO2002077027A1 (en) * 2000-03-23 2002-10-03 Curagen Corporation Human stra6-like protein and nucleic acids encoding the same
US7301008B2 (en) * 2000-06-05 2007-11-27 Genentech, Inc. PRO7174 polypeptides
US20030187201A1 (en) * 2000-09-15 2003-10-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7157558B2 (en) * 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
WO2001012660A2 (en) * 1999-08-17 2001-02-22 Sagami Chemical Research Center HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOUILLET PHILIPPE ET AL: "Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein.", MECHANISMS OF DEVELOPMENT, vol. 63, no. 2, 1997, pages 173 - 186, XP001002219, ISSN: 0925-4773 *
DATABASE EMBL 28 May 1999 (1999-05-28), STRAUSBERG, R.: "wa85b10.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:2302939 3', mRNA sequence.", XP002174857 *
DATABASE EMBL 30 June 1999 (1999-06-30), STRAUSBERG, R.: "wg58f06.x1 Soares_NSF_F8_9W_OT_PA_P_S1 Homo sapiens cDNA clone IMAGE:2369315 3', mRNA sequence.", XP002174858 *

Also Published As

Publication number Publication date
AU785055B2 (en) 2006-09-07
PT1246917E (en) 2009-06-02
AU2006241374B2 (en) 2009-10-22
US7741439B2 (en) 2010-06-22
AU3276801A (en) 2001-07-24
CN1425066A (en) 2003-06-18
KR20080006002A (en) 2008-01-15
US7173115B2 (en) 2007-02-06
JP2003519491A (en) 2003-06-24
JP5701624B2 (en) 2015-04-15
IL150676A0 (en) 2003-02-12
WO2001051635A2 (en) 2001-07-19
CN101643733A (en) 2010-02-10
US20110171238A1 (en) 2011-07-14
CN1425066B (en) 2010-05-26
NZ520095A (en) 2004-05-28
DE60137829D1 (en) 2009-04-16
US20020173461A1 (en) 2002-11-21
US7939650B2 (en) 2011-05-10
US20070128188A1 (en) 2007-06-07
KR100929057B1 (en) 2009-11-30
EP1246917A2 (en) 2002-10-09
US7855278B2 (en) 2010-12-21
JP2011103891A (en) 2011-06-02
CA2397207C (en) 2013-12-03
EP1246917B1 (en) 2009-03-04
KR20020073168A (en) 2002-09-19
US20020156252A1 (en) 2002-10-24
US20080299547A1 (en) 2008-12-04
IL150676A (en) 2010-05-17
ATE424457T1 (en) 2009-03-15
AU2006241374A1 (en) 2006-12-14
CA2397207A1 (en) 2001-07-19
DK1246917T3 (en) 2009-06-08
US20070025998A1 (en) 2007-02-01
ES2323220T3 (en) 2009-07-09
US20090010936A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
WO1999063088A8 (en) Membrane-bound proteins and nucleic acids encoding the same
WO1999028462A3 (en) Polypeptides and nucleic acids encoding the same
WO1999061469A3 (en) Prostate growth-associated membrane proteins
WO2001068848A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002008288A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999014328A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001051635A3 (en) Novel stra6 polypeptides
WO2001016318A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001040466A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000053756A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000077037A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002024888A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001007611A3 (en) Novel polynucleotides and method for the use thereof
AU3774300A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000015796A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000036102A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000056889A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000039297A3 (en) Il-1 related polypeptides
WO2003076569A3 (en) Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
WO2000068376A8 (en) Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
EP1241179A3 (en) Human cornichon-like protein and nucleic acids encoding it
KR100515858B1 (en) PRO617 Polypeptides
EP1251139A3 (en) Human mindin-like protein and nucleic acids encoding it
EP1241187A3 (en) Fibilin-like polypeptide and nucleic acids encoding the same
EP1241250A3 (en) Human dehydrogenase-like protein and nucleic acid encoding it

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 32768/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 150676

Country of ref document: IL

Ref document number: 520095

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2397207

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020027009049

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2001 551209

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2001904821

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 018064965

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020027009049

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001904821

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 520095

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 520095

Country of ref document: NZ